Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteasome inhibition: a new anti-inflammatory strategy.
Elliott PJ, Zollner TM, Boehncke WH. Elliott PJ, et al. J Mol Med (Berl). 2003 Apr;81(4):235-45. doi: 10.1007/s00109-003-0422-2. Epub 2003 Mar 26. J Mol Med (Berl). 2003. PMID: 12700891 Review.
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.
Pye J, Ardeshirpour F, McCain A, Bellinger DA, Merricks E, Adams J, Elliott PJ, Pien C, Fischer TH, Baldwin AS Jr, Nichols TC. Pye J, et al. Among authors: elliott pj. Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H919-26. doi: 10.1152/ajpheart.00851.2002. Epub 2002 Nov 7. Am J Physiol Heart Circ Physiol. 2003. PMID: 12424098 Free article.
Assays for proteasome inhibition.
Elliott PJ, Soucy TA, Pien CS, Adams J, Lightcap ES. Elliott PJ, et al. Methods Mol Med. 2003;85:163-72. doi: 10.1385/1-59259-380-1:163. Methods Mol Med. 2003. PMID: 12710207 Review. No abstract available.
Proteasome inhibition: A novel mechanism to combat asthma.
Elliott PJ, Pien CS, McCormack TA, Chapman ID, Adams J. Elliott PJ, et al. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):294-300. doi: 10.1016/s0091-6749(99)70369-6. J Allergy Clin Immunol. 1999. PMID: 10452747
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
Papandreou CN, Daliani DD, Nix D, Yang H, Madden T, Wang X, Pien CS, Millikan RE, Tu SM, Pagliaro L, Kim J, Adams J, Elliott P, Esseltine D, Petrusich A, Dieringer P, Perez C, Logothetis CJ. Papandreou CN, et al. J Clin Oncol. 2004 Jun 1;22(11):2108-21. doi: 10.1200/JCO.2004.02.106. J Clin Oncol. 2004. PMID: 15169797 Clinical Trial.
106 results